MaxCyte (MXCT) said Monday it has completed an operational review which resulted in a 15% reduction of its workforce, affecting 21 positions and saving about $5.8 million in 2025.
The layoffs and other personnel decisions will bring its headcount to 116 employees by the end of 2024, compared with 143 at the end of 2023, the company said.
MaxCute also raised its full-year 2024 core revenue guidance to 6% to 8% growth, up from its previous guidance of at least 5% growth.
Analysts polled by FactSet expect sales of $37.7 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.